Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples

1 Jun 2020

Abstract excerpt

Abstract Background The rising incidence of renal cell carcinomas (RCC) constitutes a significant challenge owing to risk of overtreatment. Because aberrant microRNA (miR) promoter methylation contributes to cancer development, we investigated whether altered miR-30a-5p expression associates with DNA promoter methylation and evaluated the usefulness as clear cell RCC (ccRCC) diagnostic and prognostic markers....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32487203
DOI: 10.1186/s13046-020-01600-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samplesPMID 32487203Read ↗

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinomaSemantic proximity Read ↗

An Overview of Epigenetics in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinomaSemantic proximity Read ↗

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.Semantic proximity Read ↗

A CpG-methylation-based assay to predict survival in clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes.Semantic proximity Read ↗

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic TreatmentsSemantic proximity Read ↗

Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinomaSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.